Technical Articles

PI3K/AKT
HER3 靶点的临床价值与 Patritumab Deruxtecan（U3-1402）的研发背景
The clinical value of HER3 target and the development background of Patritumab Deruxtecan (U3-1402)
发布时间 2025-07-09
The human epidermal growth factor receptor (HER) family plays a key role in the occurrence and development of tumors, among which EGFR (HER1) and HER2 have been widely used as classic therapeutic targets in clinical practice, while HER3 (ERBB3), although started relatively late in research, has gradually gained attention in terms of its biological significance
View details
  • Cancer
  • Her3
  • PI3K/AKT
  • HER
Total 1
  • 1
Go to
UA
Link：
Products
Application
Cell FactorTarget Proteins
Custom Services
Custom Protein Expression ServicesCustom SPR Services
About Us
PromotionTechnical ArticlesProduct ApplicationFAQsCitationsAbout Us
We Media：
Facebook Linkedin YouTube X Thraeds Pinterest
©2021-2026 all rights reserved UA Biotechnology Co.,Ltd.
Privacy Policy
网站备案号 浙ICP备2022019033号-2 浙公网安备33010202004867号
 Business license (three certificates in one)
Tel：+86-25-56221161
E-mail：order@ua-bio.com
All products sold on this website shall not be used for clinical diagnosis or treatment of humans or animals, and shall only be used for non-medical purposes such as industrial or scientific research.